Ill STAT. 2374 PUBLIC LAW 105-115—NOV. 21, 1997 "SUBCHAPTER F—NATIONAL UNIFORMITY FOR NONPRESCRIPTION DRUGS AND PREEMPTION FOR LABELING OR PACKAGING OF COS- METICS 21 USE 379R. "SEC. 751. NATIONAL UNIFORMITY FOR NONPRESCRIPTION DRUGS. "(a) IN GENERAL. —Except as provided in subsection (b), (c)(1), (d), (e), or (f), no State or political subdivision of a State may establish or continue in effect any requirement— "(1) that relates to the regulation of a drug that is not subject to the requirements of section 503(b)(1) or 503(f)(1)(A); ana "(2) that is different from or in addition to, or that is otherwise not identical with, a requirement under this Act, the Poison Prevention Packaging Act of 1970 (15 U.S.C. 1471 et seq,), or the Fair Packaging and Labeling Act (15 U.S.C. 1451 et seq.). "(b) EXEMPTION.— "(1) IN GENERAL.— Upon application of a State or political subdivision thereof, the Secretary may by regulation, after notice and opportunity for written and oral presentation of views, exempt from subsection (a), under such conditions as may be prescribed in such regulation, a State or political subdivision requirement that— "(A) protects an important public interest that would otherwise be unprotected, including the health and safety of children; "(B) would not cause any drug to be in violation of any applicable requirement or prohibition under Federal law; and "(C) would not imduly burden interstate commerce. "(2) TIMELY ACTION.—The Secretary shall make a decision on the exemption of a State or political subdivision requirement under paragraph (1) not later than 120 days after receiving the application of the State or political subdivision under paragraph (1). " (c) SCOPE.— "(1) IN GENERAL.—T h is section shall not apply to— "(A) any State or political subdivision requirement that relates to the practice of pharmacy; or "(B) any State or political subdivision requirement that a drug be dispensed only upon the prescription of a practitioner licensed by law to administer such drug. "(2) SAFETY OR EFFECTIVENESS.—For purposes of subsection (a), a requirement that relates to the regulation of a drug shall be deemed to include any requirement relating to public information or any other form of public communication relating to a warning of any kind for a drug. "(d) EXCEPTIONS. — "(1) IN GENERAL. —In the case of a drug described in subsection (a)(1) that is not the subject of an application approved under section 505 or section 507 (as in effect on the day before the date of enactment of the Food and Drug Administration Modernization Act of 1997) or a final regulation promulgated by the Secretary establishing conditions under which the drug is generally recognized as safe and effective and not misbranded, subsection (a) shall apply only with respect to a requirement of a State or political subdivision of a State that
�
